Tendyne™ (TMVR system)Product Code (REF): TENDV-SP-39M
Tendyne™ transcatheter mitral valve replacement (TMVR) improves patients' function and quality of life by offering select patients with symptomatic, significant MR (≥ grade 3) a less invasive mitral valve replacement option over conventional mitral valve surgery. Tendyne TMVR provides symptom relief by eliminating MR, and is performed as a beating-heart procedure without the need for cardiopulmonary bypass or rapid pacing. Reported clinical outcomes include complete MR elimination in 99% of patients at 30 days, sustained MR elimination in 93% of patients at 2 years, a 96% technical success rate (per Mitral Valve Academic Research Consortium, MVARC), significant improvement in symptom and quality-of-life measures, and a low mean mitral gradient of 3.2 mm Hg at 2 years. The system is fully repositionable and retrievable at any point intraprocedurally. The Tendyne™ valve is designed for the mitral anatomy to eliminate MR and is supplied in SP and LP models across a range of valve numbers — 39M, 29S, 29L, 33S and 35M — with device AP dimensions from 29.0 to 38.5 mm and effective orifice areas up to 3.0 cm². The implantation and retrieval system comprises the Tendyne™ loading, delivery, pad position and Gen 2 retrieval systems; the delivery and retrieval systems use a 36 F sheath ID.
Available under product codes TENDV-SP-39M, TENDV-LP-29S, TENDV-LP-29L, TENDV-LP-33S, TENDV-LP-35M.
Sizes & Specifications
- Therapy
- Transcatheter mitral valve replacement (TMVR)
- Valve models
- SP (39M) and LP (29S, 29L, 33S, 35M)
- Device AP
- 29.0–38.5 mm
- Effective orifice area
- 2.2–3.0 cm²
- Delivery/retrieval sheath ID
- 36 F
Manufacturer: Abbott Laboratories · Reference source: cardiovascular.abbott
Design & Technology
Technical characteristics and diagrams as published by Abbott.
Designed for the mitral anatomy to eliminate MR
Product Identification & Specifications
Reference identifiers for procurement, registration and tender documentation.
| Product Code | TENDV-SP-39M |
|---|---|
| REF Numbers | TENDV-SP-39M, TENDV-LP-29S, TENDV-LP-29L, TENDV-LP-33S, TENDV-LP-35M |
| Manufacturer | Abbott Laboratories |
| Brand | Abbott |
| Product Family | Transcatheter Valve Solutions |
| Country Availability | Tajikistan, Afghanistan |
Clinical Applications
The Tendyne™ (TMVR system) is a repositionable, retrievable transcatheter mitral valve replacement (tmvr) system in the Transcatheter Valve Solutions family from Abbott Laboratories, used by interventional specialists in procedures where a repositionable, retrievable transcatheter mitral valve replacement (tmvr) system of this class is indicated. It is supplied in 5 configurations (catalog codes TENDV-SP-39M through TENDV-LP-35M) to match anatomical and procedural requirements.
For the complete indications for use, contraindications and instructions for use (IFU), request the official Abbott documentation through our clinical team. Modern Medical Solutions supplies the Tendyne™ (TMVR system) to hospitals and cath labs across Tajikistan and Afghanistan.
Ordering Information
Catalog reference codes as published by Abbott. Contact us to confirm current availability.
| Model | Valve Number | Catalog Number | Device AP (mm) | Device IC (mm) | Device Perimeter (mm) | EOA (cm²) |
|---|---|---|---|---|---|---|
| SP | 39M | TENDV-SP-39M | 38.5 | 50.5 | 156 | 3.0 |
| LP | 29S | TENDV-LP-29S | 29.0 | 42.5 | 119 | 2.2 |
| LP | 29L | TENDV-LP-29L | 29.0 | 47.5 | 129 | |
| LP | 33S | TENDV-LP-33S | 32.5 | 43.5 | 130 | |
| LP | 35M | TENDV-LP-35M | 34.5 | 48.5 | 144 |
Model, valve number and catalog numbers transcribed from the Abbott Tendyne™ TMVR Ordering Information section (valve product specifications and implantation/retrieval system). Item approved for OUS use only.
Downloads & Documentation
Instructions for use (IFU), technical datasheets and clinical literature for the Tendyne™ (TMVR system) are available on request from our clinical team.
Request DocumentationFrequently Asked Questions
- Who is Tendyne™ TMVR intended for?
- Tendyne™ transcatheter mitral valve replacement is intended for select patients with symptomatic, significant mitral regurgitation (MR ≥ grade 3), offering a less invasive mitral valve replacement option over conventional mitral valve surgery.
- Is the Tendyne™ procedure performed on cardiopulmonary bypass?
- No. Tendyne™ TMVR is a beating-heart procedure performed without the need for cardiopulmonary bypass or rapid pacing. The system is also fully repositionable and retrievable at any point intraprocedurally.
- What are the reported clinical outcomes for Tendyne™?
- Reported outcomes include complete MR elimination in 99% of patients at 30 days, sustained MR elimination in 93% of patients at 2 years, a 96% technical success rate (per MVARC), and a low mean mitral gradient of 3.2 mm Hg at 2 years, with significant improvement in symptom and quality-of-life measures.
- What valve sizes and delivery components are available?
- The valve is supplied in SP (39M) and LP (29S, 29L, 33S, 35M) models with device AP dimensions from 29.0 to 38.5 mm and EOA up to 3.0 cm². The implantation and retrieval system includes the Tendyne™ loading system (TENDV-LS), delivery system (TENDV-DS), pad position system (TENDV-PS) and Gen 2 retrieval system (TENDV-RS2); the delivery and retrieval systems use a 36 F sheath ID.
